A multi-target computational approach to target the polycystic ovary syndrome receptors using natural compounds
Abstract
Abstract Background Polycystic ovary syndrome (PCOS) is a prevalent endocrinopathy characterized by excess androgen production and associated metabolic disturbances. Although several synthetic drugs, such as hypoglycemic and ovulation-inducing agents, are used in PCOS management, their clinical outcomes remain limited due to adverse side effects. Therefore, natural compounds offer promising alternatives or adjunct drugs with improved safety and efficacy. Objective and methods This study evaluated phytochemicals from Anethum graveolens (dill) for potential therapeutic activity against PCOS using an integrative computational strategy. PCOS-related targets were identified through DiseaseNet and GeneCards, followed by protein–protein interaction (PPI) analysis via STRING and hub gene selection with CytoHubba. Lead compounds were assessed through molecular docking, density functional theory (DFT) calculations, and to confirm the stability of the compound–target interactions, we performed molecular dynamics (MD) simulations (100 ns). Results The selected phytochemicals demonstrated favorable drug-likeness properties. DFT analysis revealed strong reactivity of carvacrol, eugenol, geraniol, and thymol, indicated by low energy gaps. Docking studies showed that these compounds exhibited stronger binding affinities with key PCOS targets compared to the control drug metformin. MD simulations further confirmed the stable interaction of these compounds with PCOS-associated proteins,…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.